Exelon is a Transdermal Patch, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Rivastigmine.
| Product ID | 0078-0503_2e2200d5-3ab6-4b69-a1e0-12d84a4a7b43 |
| NDC | 0078-0503 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Exelon |
| Generic Name | Rivastigmine |
| Dosage Form | Patch, Extended Release |
| Route of Administration | TRANSDERMAL |
| Marketing Start Date | 2007-07-06 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022083 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | RIVASTIGMINE |
| Active Ingredient Strength | 13 mg/24h |
| Pharm Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2007-07-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022083 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-07-06 |
| Marketing Category | NDA |
| Application Number | NDA022083 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-07-06 |
| Ingredient | Strength |
|---|---|
| RIVASTIGMINE | 13.3 mg/24h |
| SPL SET ID: | 07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0078-0323 | Exelon | rivastigmine tartrate |
| 0078-0324 | Exelon | rivastigmine tartrate |
| 0078-0325 | Exelon | rivastigmine tartrate |
| 0078-0326 | Exelon | rivastigmine tartrate |
| 0078-0501 | Exelon | rivastigmine |
| 0078-0502 | Exelon | rivastigmine |
| 0078-0503 | Exelon | rivastigmine |
| 21695-357 | Exelon | Exelon |
| 0378-9070 | Rivastigmine | rivastigmine |
| 0378-9071 | Rivastigmine | rivastigmine |
| 0378-9072 | Rivastigmine | rivastigmine |
| 0781-7304 | Rivastigmine | rivastigmine |
| 0781-7309 | Rivastigmine | rivastigmine |
| 0781-7313 | Rivastigmine | rivastigmine |
| 16714-115 | Rivastigmine | Rivastigmine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EXELON 97977525 not registered Live/Pending |
Exelon Corporation 2021-11-05 |
![]() EXELON 97977523 not registered Live/Pending |
Exelon Corporation 2021-11-05 |
![]() EXELON 97110038 not registered Live/Pending |
Exelon Corporation 2021-11-05 |
![]() EXELON 97110036 not registered Live/Pending |
Exelon Corporation 2021-11-05 |
![]() EXELON 86776336 5508909 Live/Registered |
Exelon Corporation 2015-10-02 |
![]() EXELON 86776333 5508908 Live/Registered |
Exelon Corporation 2015-10-02 |
![]() EXELON 86302338 4671120 Live/Registered |
Exelon Corporation 2014-06-06 |
![]() EXELON 85982666 not registered Dead/Abandoned |
Exelon Corporation 2012-05-24 |
![]() EXELON 85982665 not registered Dead/Abandoned |
Exelon Corporation 2012-05-24 |
![]() EXELON 85980324 4445212 Live/Registered |
Exelon Corporation 2012-05-24 |
![]() EXELON 85980323 4445211 Live/Registered |
Exelon Corporation 2012-05-24 |
![]() EXELON 85634507 not registered Dead/Abandoned |
Exelon Corporation 2012-05-24 |